Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis.
Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis. Gene Ther. 2003 Jul; 10(13):1067-78.
View in:
PubMed
subject areas
Adenoviridae
Animals
Apoptosis
Chemokine CCL20
Chemokines, CC
Colonic Neoplasms
Female
Genetic Therapy
Genetic Vectors
Immunotherapy
Interferon-gamma
Interleukin-12
Macrophage Inflammatory Proteins
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Neoplasms, Experimental
Oligonucleotide Array Sequence Analysis
Pancreatic Neoplasms
Receptors, CCR6
Receptors, Chemokine
Receptors, Interferon
Reverse Transcriptase Polymerase Chain Reaction
Transduction, Genetic
Tumor Cells, Cultured
Tumor Escape
authors with profiles
Ainhoa Arina